{"transactions":[{"id":735992,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T20:05:18.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":31000,"derivative":{"exercise_price":3.94,"exercise_date":"2027-06-15","expiration_date":"2036-06-14","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001213900-26-069247","document":"marketforms-73184.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1227835/000121390026069247/marketforms-73184.xml","form_type":"4"}},{"id":1111291,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:05:27.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":24000,"derivative":{"exercise_price":3.26,"exercise_date":"2026-06-12","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001213900-25-054286","document":"marketforms-69816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1227835/000121390025054286/marketforms-69816.xml","form_type":"4"}},{"id":1279634,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-02-07T19:39:57.000Z","date":"2025-02-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8147,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents restricted stock units (\"RSUs\") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"At the Effective Time, each unvested RSU was cancelled and converted solely into the right to receive a cash payment of $12.50 per share of common stock subject to such unvested RSU, without interest, subject to the terms and conditions of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"At the Effective Time, each unvested RSU was cancelled and converted solely into the right to receive a cash payment of $12.50 per share of common stock subject to such unvested RSU, without interest, subject to the terms and conditions of the Merger Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"At the Effective Time, each unvested RSU was cancelled and converted solely into the right to receive a cash payment of $12.50 per share of common stock subject to such unvested RSU, without interest, subject to the terms and conditions of the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8147},"source":{"system":"sec-edgar","filing":"0001683168-25-000862","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316825000862/ownership.xml","form_type":"4"}},{"id":1279633,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-07T19:39:57.000Z","date":"2025-02-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10030,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents stock options (\"Options\") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":10.72,"expiration_date":"2027-12-14","underlying":"Common Stock","underlying_shares":10030},"source":{"system":"sec-edgar","filing":"0001683168-25-000862","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316825000862/ownership.xml","form_type":"4"}},{"id":1279632,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option right to buy)","published_at":"2025-02-07T19:39:57.000Z","date":"2025-02-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":19675,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents stock options (\"Options\") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement."}],"balance_after":10030,"derivative":{"exercise_price":6.87,"expiration_date":"2027-01-09","underlying":"Common Stock","underlying_shares":19675},"source":{"system":"sec-edgar","filing":"0001683168-25-000862","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316825000862/ownership.xml","form_type":"4"}},{"id":1279631,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-07T19:39:57.000Z","date":"2025-02-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":19600,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents stock options (\"Options\") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement."}],"balance_after":29705,"derivative":{"exercise_price":5.22,"expiration_date":"2025-12-14","underlying":"Common Stock","underlying_shares":19600},"source":{"system":"sec-edgar","filing":"0001683168-25-000862","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316825000862/ownership.xml","form_type":"4"}},{"id":1279630,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-07T19:39:57.000Z","date":"2025-02-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents stock options (\"Options\") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement."}],"balance_after":49305,"derivative":{"exercise_price":4.67,"expiration_date":"2027-11-27","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001683168-25-000862","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316825000862/ownership.xml","form_type":"4"}},{"id":1279629,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2025-02-07T19:39:57.000Z","date":"2025-02-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":36368,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock that were disposed of at the effective time (the \"Effective Time\") of the merger (the \"Merger\") of Space Mergerco, Inc. (\"Merger Sub\") with and into Avid Bioservices, Inc. (the \"Issuer\") pursuant to the Agreement and Plan of Merger, dated as of November 6, 2024 (the \"Merger Agreement\"), by and among the Issuer, Space Finco, Inc., and Merger Sub."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each outstanding share of common stock was cancelled and converted into the right to receive a cash payment per share of $12.50, without interest, subject to the terms and conditions of the Merger Agreement (the \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001683168-25-000862","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316825000862/ownership.xml","form_type":"4"}},{"id":1329987,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-12-17T19:49:09.000Z","date":"2024-12-14","kind":"grant","planned":false,"acquired":true,"shares":8147,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Annual equity award grant pursuant to the Issuer's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs granted to the reporting person on December 14, 2024 shall fully vest on December 14, 2025, subject to the reporting person's continuous service to the Issuer on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSUs granted to the reporting person on December 14, 2024 shall fully vest on December 14, 2025, subject to the reporting person's continuous service to the Issuer on such vesting date."}],"balance_after":8147,"derivative":{"underlying":"Common Stock","underlying_shares":8147},"source":{"system":"sec-edgar","filing":"0001683168-24-008804","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316824008804/ownership.xml","form_type":"4"}},{"id":1329986,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-12-17T19:49:09.000Z","date":"2024-12-14","kind":"exercise","planned":false,"acquired":false,"shares":26756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs granted to the reporting person on December 14, 2023 pursuant to the Issuer's non-employee director compensation program fully vested on December 14, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"RSUs granted to the reporting person on December 14, 2023 pursuant to the Issuer's non-employee director compensation program fully vested on December 14, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":26756},"source":{"system":"sec-edgar","filing":"0001683168-24-008804","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316824008804/ownership.xml","form_type":"4"}},{"id":1329985,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2024-12-17T19:49:09.000Z","date":"2024-12-14","kind":"exercise","planned":false,"acquired":true,"shares":26756,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."}],"balance_after":36368,"source":{"system":"sec-edgar","filing":"0001683168-24-008804","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316824008804/ownership.xml","form_type":"4"}},{"id":1484658,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-10T22:00:20.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":10000,"derivative":{"exercise_price":2.67,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-24-051379","document":"marketforms-66262.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1227835/000121390024051379/marketforms-66262.xml","form_type":"4"}},{"id":1708305,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-12-18T19:33:03.000Z","date":"2023-12-14","kind":"grant","planned":false,"acquired":true,"shares":26756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Annual equity award grant pursuant to the Issuer's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs granted to the reporting person on December 14, 2023 shall fully vest on December 14, 2024, subject to the reporting person's continuous service to the Issuer on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSUs granted to the reporting person on December 14, 2023 shall fully vest on December 14, 2024, subject to the reporting person's continuous service to the Issuer on such vesting date."}],"balance_after":26756,"derivative":{"underlying":"Common Stock","underlying_shares":26756},"source":{"system":"sec-edgar","filing":"0001683168-23-008944","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316823008944/ownership.xml","form_type":"4"}},{"id":1708304,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-12-18T19:33:03.000Z","date":"2023-12-14","kind":"exercise","planned":false,"acquired":false,"shares":9612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs granted to the reporting person on December 14, 2022 pursuant to the Issuer's non-employee director compensation program fully vested on December 14, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"RSUs granted to the reporting person on December 14, 2022 pursuant to the Issuer's non-employee director compensation program fully vested on December 14, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9612},"source":{"system":"sec-edgar","filing":"0001683168-23-008944","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316823008944/ownership.xml","form_type":"4"}},{"id":1708303,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2023-12-18T19:33:03.000Z","date":"2023-12-14","kind":"exercise","planned":false,"acquired":true,"shares":9612,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."}],"balance_after":9612,"source":{"system":"sec-edgar","filing":"0001683168-23-008944","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316823008944/ownership.xml","form_type":"4"}},{"id":1861996,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T20:10:48.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":10000,"derivative":{"exercise_price":2.85,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-23-047469","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1227835/000121390023047469/ownership.xml","form_type":"4"}},{"id":1921428,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2023-04-12T19:34:31.000Z","date":"2023-04-11","kind":"sale","planned":false,"acquired":false,"shares":7011,"price":20.2423,"value":141918.7653,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a weighted average sales price per share. These shares were sold at prices ranging from $20.09 to $20.33. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001683168-23-002321","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316823002321/ownership.xml","form_type":"4"}},{"id":2084528,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-12-16T20:01:45.000Z","date":"2022-12-14","kind":"grant","acquired":true,"shares":9612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Annual equity award grant pursuant to the Issuer's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs granted to the reported person on December 14, 2022 shall fully vest on December 14, 2023, subject to the reporting person's continuous service to the Issuer on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs granted to the reported person on December 14, 2022 shall fully vest on December 14, 2023, subject to the reporting person's continuous service to the Issuer on such vesting date."}],"balance_after":9612,"derivative":{"underlying":"Common Stock","underlying_shares":9612},"source":{"system":"sec-edgar","filing":"0001683168-22-008498","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316822008498/ownership.xml","form_type":"4"}},{"id":2084527,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-12-16T20:01:45.000Z","date":"2022-12-14","kind":"exercise","acquired":false,"shares":4632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs granted to the reporting person on December 14, 2021 pursuant to the Issuer's non-employee director compensation program which fully vested on December 14, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"RSUs granted to the reporting person on December 14, 2021 pursuant to the Issuer's non-employee director compensation program which fully vested on December 14, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4632},"source":{"system":"sec-edgar","filing":"0001683168-22-008498","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316822008498/ownership.xml","form_type":"4"}},{"id":2084526,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2022-12-16T20:01:45.000Z","date":"2022-12-14","kind":"exercise","acquired":true,"shares":4632,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."}],"balance_after":7011,"source":{"system":"sec-edgar","filing":"0001683168-22-008498","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316822008498/ownership.xml","form_type":"4"}},{"id":2237492,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T20:10:22.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":10000,"derivative":{"exercise_price":3.5,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-22-031992","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1227835/000121390022031992/ownership.xml","form_type":"4"}},{"id":2470823,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-12-16T21:34:45.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":4632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Annual equity award grant pursuant to the Issuer's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs granted to the reporting person shall fully vest on December 14, 2022, subject to the reporting person's continuous service to the Issuer on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs granted to the reporting person shall fully vest on December 14, 2022, subject to the reporting person's continuous service to the Issuer on such vesting date."}],"balance_after":4632,"derivative":{"underlying":"Common Stock","underlying_shares":4632},"source":{"system":"sec-edgar","filing":"0001683168-21-006440","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316821006440/ownership.xml","form_type":"4"}},{"id":2470822,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-12-16T21:34:45.000Z","date":"2021-12-14","kind":"exercise","acquired":false,"shares":2379,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs granted to the reporting person on December 14, 2020 fully vested on December 14, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"RSUs granted to the reporting person on December 14, 2020 fully vested on December 14, 2021."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2379},"source":{"system":"sec-edgar","filing":"0001683168-21-006440","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316821006440/ownership.xml","form_type":"4"}},{"id":2470821,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par balue","published_at":"2021-12-16T21:34:45.000Z","date":"2021-12-14","kind":"exercise","acquired":true,"shares":2379,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock."}],"balance_after":2379,"source":{"system":"sec-edgar","filing":"0001683168-21-006440","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316821006440/ownership.xml","form_type":"4"}},{"id":2673637,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-11T00:07:03.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":10000,"derivative":{"exercise_price":10.51,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-039685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1227835/000120919121039685/doc4.xml","form_type":"4"}},{"id":2943670,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-12-16T20:00:32.000Z","date":"2020-12-14","kind":"grant","acquired":true,"shares":2379,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"Annual grant of equity awards pursuant to the Issuer's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of each equity award granted to the reporting person shall vest on December 14, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of each equity award granted to the reporting person shall vest on December 14, 2021."}],"balance_after":2379,"derivative":{"exercise_date":"2021-12-14","underlying":"Common Stock","underlying_shares":2379},"source":{"system":"sec-edgar","filing":"0001683168-20-004318","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316820004318/ownership.xml","form_type":"4"}},{"id":2943669,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-16T20:00:32.000Z","date":"2020-12-14","kind":"grant","acquired":true,"shares":10030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual grant of equity awards pursuant to the Issuer's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of each equity award granted to the reporting person shall vest on December 14, 2021."}],"balance_after":124305,"derivative":{"exercise_price":10.72,"exercise_date":"2021-12-14","expiration_date":"2027-12-14","underlying":"Common Stock","underlying_shares":10030},"source":{"system":"sec-edgar","filing":"0001683168-20-004318","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316820004318/ownership.xml","form_type":"4"}},{"id":3113155,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T17:42:15.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":9000,"derivative":{"exercise_price":35,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-20-035851","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1227835/000120919120035851/doc4.xml","form_type":"4"}},{"id":3312476,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-14T00:20:33.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (\"RSUs\"), each one of which represents a contingent right to receive one share of Issuer's common stock. 50% of the shares vest on January 10, 2021 and 1/24th of the shares vest monthly thereafter. Settlement for the RSUs is deferred until the earliest to occur of (i) the Reporting Person's termination of service, (ii) death, (iii) disability and (iv) a change in control of the Issuer. In the event of a change in control of the Issuer, the RSUs will vest in full."}],"balance_after":31000,"source":{"system":"sec-edgar","filing":"0001209191-20-003241","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1227835/000120919120003241/doc4.xml","form_type":"4"}},{"id":3312896,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-13T20:35:38.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":19675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual grant of stock options pursuant to the Issuer's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option fully vests one year from the date of grant."}],"balance_after":114275,"derivative":{"exercise_price":6.87,"exercise_date":"2021-01-09","expiration_date":"2027-01-09","underlying":"Common Stock","underlying_shares":19675},"source":{"system":"sec-edgar","filing":"0001683168-20-000108","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316820000108/ownership.xml","form_type":"4"}},{"id":3351653,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP, Corp. Dev."}}],"security":"Stock Option (right to buy)","published_at":"2019-12-05T13:42:16.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":53.605,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-059248","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059248/doc4.xml","form_type":"4"}},{"id":3351652,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP, Corp. Dev."}}],"security":"Stock Option (right to buy)","published_at":"2019-12-05T13:42:16.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":45.635,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-059248","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059248/doc4.xml","form_type":"4"}},{"id":3351651,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP, Corp. Dev."}}],"security":"Stock Option (right to buy)","published_at":"2019-12-05T13:42:16.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":40.65,"underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001209191-19-059248","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059248/doc4.xml","form_type":"4"}},{"id":3351650,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP, Corp. Dev."}}],"security":"Stock Option (right to buy)","published_at":"2019-12-05T13:42:16.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":41.36,"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-059248","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059248/doc4.xml","form_type":"4"}},{"id":3351649,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP, Corp. Dev."}}],"security":"Stock Option (right to buy)","published_at":"2019-12-05T13:42:16.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration.  The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":17.81,"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-19-059248","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059248/doc4.xml","form_type":"4"}},{"id":3351648,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP, Corp. Dev."}}],"security":"Common Stock","published_at":"2019-12-05T13:42:16.000Z","date":"2019-12-04","kind":"sale","acquired":false,"shares":165925,"price":60,"value":9955500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Disposed of for $60.00 per share pursuant to the terms of that certain Agreement and Plan of Merger dated as of August 7, 2019, by and among Catalog Intermediate Inc. (\"Parent\"), Catalog Merger Sub (\"Merger Sub\"), each entities controlled by investment funds advised by Permira Advisors LLC, and the Company (the \"Merger Agreement\").  All terms capitalized but not defined shall have the respective meanings given to them in the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-059248","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059248/doc4.xml","form_type":"4"}},{"id":3351647,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP, Corp. Dev."}}],"security":"Common Stock","published_at":"2019-12-05T13:42:16.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":43500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each Company restricted stock unit subject to performance-vesting conditions (each, a \"Company PSU\") that was outstanding immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00, multiplied by the total number of shares of Company Common Stock subject to such Company PSU, with any performance-based vesting conditions deemed achieved at the greater of (x) target levels of performance and (y) actual levels of performance, without pro-ration."}],"balance_after":165925,"source":{"system":"sec-edgar","filing":"0001209191-19-059248","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059248/doc4.xml","form_type":"4"}},{"id":3351646,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP, Corp. Dev."}}],"security":"Common Stock","published_at":"2019-12-05T13:42:16.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":20000,"price":53.605,"value":1072100.0,"ownership":{"direct":true},"balance_after":122425,"source":{"system":"sec-edgar","filing":"0001209191-19-059248","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059248/doc4.xml","form_type":"4"}},{"id":3351645,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP, Corp. Dev."}}],"security":"Common Stock","published_at":"2019-12-05T13:42:16.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":25000,"price":45.635,"value":1140875.0,"ownership":{"direct":true},"balance_after":102425,"source":{"system":"sec-edgar","filing":"0001209191-19-059248","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059248/doc4.xml","form_type":"4"}},{"id":3351644,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP, Corp. Dev."}}],"security":"Common Stock","published_at":"2019-12-05T13:42:16.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":22500,"price":40.65,"value":914625.0,"ownership":{"direct":true},"balance_after":77425,"source":{"system":"sec-edgar","filing":"0001209191-19-059248","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059248/doc4.xml","form_type":"4"}},{"id":3351643,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP, Corp. Dev."}}],"security":"Common Stock","published_at":"2019-12-05T13:42:16.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":15000,"price":41.36,"value":620400.0,"ownership":{"direct":true},"balance_after":54925,"source":{"system":"sec-edgar","filing":"0001209191-19-059248","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059248/doc4.xml","form_type":"4"}},{"id":3351642,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP, Corp. Dev."}}],"security":"Common Stock","published_at":"2019-12-05T13:42:16.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":7500,"price":17.81,"value":133575.0,"ownership":{"direct":true},"balance_after":39925,"source":{"system":"sec-edgar","filing":"0001209191-19-059248","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119059248/doc4.xml","form_type":"4"}},{"id":3651684,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP, Corp. Dev."}}],"security":"Common Stock","published_at":"2019-02-19T17:07:24.000Z","date":"2019-02-15","kind":"sale","acquired":false,"shares":5802,"price":37.45,"value":217284.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Broker-assisted sale of 5,802 shares to cover the payment of withholding tax liability from the settlement of a performance share award."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.32 to $37.57 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 3 to this Form 4."}],"balance_after":32425,"source":{"system":"sec-edgar","filing":"0001209191-19-011184","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119011184/doc4.xml","form_type":"4"}},{"id":3651683,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP, Corp. Dev."}}],"security":"Common Stock","published_at":"2019-02-19T17:07:24.000Z","date":"2019-02-15","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to settlement of a performance share award."}],"balance_after":38227,"source":{"system":"sec-edgar","filing":"0001209191-19-011184","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119011184/doc4.xml","form_type":"4"}},{"id":3678555,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Development"}}],"security":"Common Stock","published_at":"2019-02-04T18:27:24.000Z","date":"2019-01-31","kind":"grant","acquired":true,"shares":6227,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents Restricted Stock Units"}],"balance_after":26227,"source":{"system":"sec-edgar","filing":"0001209191-19-006988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919119006988/doc4.xml","form_type":"4"}},{"id":3728258,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-18T20:24:03.000Z","date":"2018-12-14","kind":"grant","acquired":true,"shares":19600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option fully vests one year from the date of grant."}],"balance_after":94600,"derivative":{"exercise_price":5.22,"exercise_date":"2019-12-14","expiration_date":"2025-12-14","underlying":"Common Stock","underlying_shares":19600},"source":{"system":"sec-edgar","filing":"0001683168-18-003746","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316818003746/ownership.xml","form_type":"4"}},{"id":3782635,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Development"}}],"security":"Stock Option (right to buy)","published_at":"2018-10-26T16:09:06.000Z","date":"2018-10-24","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option representing a right to purchase 20,000 shares becomes exercisable in four equal installments beginning October 24, 2019, which is the first anniversary of the date on which the option was granted."}],"balance_after":20000,"derivative":{"exercise_price":53.605,"expiration_date":"2025-10-24","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-18-056288","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919118056288/doc4.xml","form_type":"4"}},{"id":3941828,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Development"}}],"security":"Stock Option (right to buy)","published_at":"2018-05-09T16:24:15.000Z","date":"2018-05-08","kind":"exercise","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option representing a right to purchase 30,000 shares became exercisable in four equal installments beginning October 26, 2017, which was the first anniversary of the date on which the option was granted."}],"balance_after":22500,"derivative":{"exercise_price":40.65,"expiration_date":"2023-10-26","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-18-028866","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919118028866/doc4.xml","form_type":"4"}},{"id":3941827,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Development"}}],"security":"Stock Option (right to buy)","published_at":"2018-05-09T16:24:15.000Z","date":"2018-05-08","kind":"exercise","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option representing a right to purchase 30,000 shares became exercisable in four equal installments beginning October 22, 2016, which was the first anniversary of the date on which the option was granted."}],"balance_after":15000,"derivative":{"exercise_price":41.36,"expiration_date":"2022-10-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-028866","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919118028866/doc4.xml","form_type":"4"}},{"id":3941826,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Development"}}],"security":"Stock Option (right to buy)","published_at":"2018-05-09T16:24:15.000Z","date":"2018-05-08","kind":"exercise","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option representing a right to purchase 30,000 shares became exercisable in four equal installments beginning October 22, 2015, which was the first anniversary of the date on which the option was granted."}],"balance_after":7500,"derivative":{"exercise_price":17.81,"expiration_date":"2021-10-22","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-18-028866","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919118028866/doc4.xml","form_type":"4"}},{"id":3941825,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Development"}}],"security":"Stock Option (right to buy)","published_at":"2018-05-09T16:24:15.000Z","date":"2018-05-08","kind":"exercise","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option representing a right to purchase 30,000 shares became exercisable in four equal installments beginning October 28, 2014, which was the first anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":16.905,"expiration_date":"2020-10-28","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-18-028866","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919118028866/doc4.xml","form_type":"4"}},{"id":3941824,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Development"}}],"security":"Common Stock","published_at":"2018-05-09T16:24:15.000Z","date":"2018-05-08","kind":"sale","acquired":false,"shares":33933,"price":49.6254,"value":1683938.6982,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.50 to $49.85 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 5 to this Form 4."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-18-028866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919118028866/doc4.xml","form_type":"4"}},{"id":3941823,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Development"}}],"security":"Common Stock","published_at":"2018-05-09T16:24:15.000Z","date":"2018-05-08","kind":"sale","acquired":false,"shares":10565,"price":49.05,"value":518213.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.50 to $49.45 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 4 to this Form 4."}],"balance_after":53933,"source":{"system":"sec-edgar","filing":"0001209191-18-028866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919118028866/doc4.xml","form_type":"4"}},{"id":3941822,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Development"}}],"security":"Common Stock","published_at":"2018-05-09T16:24:15.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":7500,"price":40.65,"value":304875.0,"ownership":{"direct":true},"balance_after":64498,"source":{"system":"sec-edgar","filing":"0001209191-18-028866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919118028866/doc4.xml","form_type":"4"}},{"id":3941821,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Development"}}],"security":"Common Stock","published_at":"2018-05-09T16:24:15.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":15000,"price":41.36,"value":620400.0,"ownership":{"direct":true},"balance_after":56998,"source":{"system":"sec-edgar","filing":"0001209191-18-028866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919118028866/doc4.xml","form_type":"4"}},{"id":3941820,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Development"}}],"security":"Common Stock","published_at":"2018-05-09T16:24:15.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":7500,"price":17.81,"value":133575.0,"ownership":{"direct":true},"balance_after":41998,"source":{"system":"sec-edgar","filing":"0001209191-18-028866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919118028866/doc4.xml","form_type":"4"}},{"id":3941819,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Development"}}],"security":"Common Stock","published_at":"2018-05-09T16:24:15.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":7500,"price":16.905,"value":126787.5,"ownership":{"direct":true},"balance_after":34498,"source":{"system":"sec-edgar","filing":"0001209191-18-028866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919118028866/doc4.xml","form_type":"4"}},{"id":3941818,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Development"}}],"security":"Common Stock","published_at":"2018-05-09T16:24:15.000Z","date":"2018-05-07","kind":"sale","acquired":false,"shares":23002,"price":49.4618,"value":1137720.3236,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Broker-assisted sale of which 14,805 shares were to cover the payment of withholding tax liability from the settlement of a performance share award."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.20 to $49.875 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 3 to this Form 4."}],"balance_after":26998,"source":{"system":"sec-edgar","filing":"0001209191-18-028866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919118028866/doc4.xml","form_type":"4"}},{"id":3941817,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Development"}}],"security":"Common Stock","published_at":"2018-05-09T16:24:15.000Z","date":"2018-05-07","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to settlement of a performance share award."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001209191-18-028866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/820081/000120919118028866/doc4.xml","form_type":"4"}},{"id":4149705,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-11-29T20:08:09.000Z","date":"2017-11-27","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in thirty-six (36) equal monthly installments over a three (3) year period beginning December 27, 2017."}],"balance_after":75000,"derivative":{"exercise_price":4.67,"exercise_date":"2017-12-27","expiration_date":"2027-11-27","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001683168-17-003189","document":"sargen_frm4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316817003189/sargen_frm4.xml","form_type":"4"}},{"id":4176906,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"officer":true,"officer_title":"EVP, Corporate Development"}}],"security":"Stock Option (right to buy)","published_at":"2017-11-01T17:14:26.000Z","date":"2017-10-30","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option representing a right to purchase a total of 25,000 shares becomes exercisable in four equal installments beginning October 30, 2018, which is the first anniversary of the date on which the option was granted."}],"balance_after":25000,"derivative":{"exercise_price":45.635,"expiration_date":"2024-10-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-17-018054","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/820081/000143774917018054/rdgdoc.xml","form_type":"4"}},{"id":4462581,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"officer":true,"officer_title":"EVP, Corporate Development"}}],"security":"Common Stock","published_at":"2017-02-08T16:47:09.000Z","date":"2017-02-07","kind":"sale","acquired":false,"shares":30000,"price":54.88,"value":1646400.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Broker-assisted sale of which 15,135 shares sold were to cover the payment of withholding tax liability arising from the settlement of performance share award"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.68 to $55.15 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 3 to this Form 4"}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001437749-17-001931","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/820081/000143774917001931/rdgdoc.xml","form_type":"4"}},{"id":4462580,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"officer":true,"officer_title":"EVP, Corporate Development"}}],"security":"Common Stock","published_at":"2017-02-08T16:47:09.000Z","date":"2017-02-07","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to settlement of a performance share award"}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001437749-17-001931","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/820081/000143774917001931/rdgdoc.xml","form_type":"4"}},{"id":4559337,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"officer":true,"officer_title":"Executive Vice President & CFO"}}],"security":"Stock Option (right to buy)","published_at":"2016-11-14T21:22:07.000Z","date":"2016-11-11","kind":"exercise","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option representing a right to purchase 30,000 shares became exercisable in four equal installments beginning October 22, 2015, which was the first anniversary of the date on which the option was granted."}],"balance_after":15000,"derivative":{"exercise_price":17.81,"expiration_date":"2021-10-22","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001437749-16-042120","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/820081/000143774916042120/rdgdoc.xml","form_type":"4"}},{"id":4559336,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"officer":true,"officer_title":"Executive Vice President & CFO"}}],"security":"Stock Option (right to buy)","published_at":"2016-11-14T21:22:07.000Z","date":"2016-11-11","kind":"exercise","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option representing a right to purchase 30,000 shares became exercisable in four equal installments beginning October 28, 2014, which was the first anniversary of the date on which the option was granted."}],"balance_after":7500,"derivative":{"exercise_price":16.91,"expiration_date":"2020-10-28","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001437749-16-042120","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/820081/000143774916042120/rdgdoc.xml","form_type":"4"}},{"id":4559335,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"officer":true,"officer_title":"Executive Vice President & CFO"}}],"security":"Stock Option (right to buy)","published_at":"2016-11-14T21:22:07.000Z","date":"2016-11-11","kind":"exercise","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option representing a right to purchase 30,000 shares became exercisable in four equal installments beginning October 24, 2013, which was the first anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":12.46,"expiration_date":"2019-10-24","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001437749-16-042120","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/820081/000143774916042120/rdgdoc.xml","form_type":"4"}},{"id":4559334,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"officer":true,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2016-11-14T21:22:07.000Z","date":"2016-11-11","kind":"sale","acquired":false,"shares":22500,"price":52.02,"value":1170450.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.85 to $52.35 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001437749-16-042120","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/820081/000143774916042120/rdgdoc.xml","form_type":"4"}},{"id":4559333,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"officer":true,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2016-11-14T21:22:07.000Z","date":"2016-11-11","kind":"exercise","acquired":true,"shares":7500,"price":17.81,"value":133575.0,"ownership":{"direct":true},"balance_after":42500,"source":{"system":"sec-edgar","filing":"0001437749-16-042120","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/820081/000143774916042120/rdgdoc.xml","form_type":"4"}},{"id":4559332,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"officer":true,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2016-11-14T21:22:07.000Z","date":"2016-11-11","kind":"exercise","acquired":true,"shares":7500,"price":16.91,"value":126825.0,"ownership":{"direct":true},"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001437749-16-042120","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/820081/000143774916042120/rdgdoc.xml","form_type":"4"}},{"id":4559331,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"officer":true,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2016-11-14T21:22:07.000Z","date":"2016-11-11","kind":"exercise","acquired":true,"shares":7500,"price":12.46,"value":93450.0,"ownership":{"direct":true},"balance_after":27500,"source":{"system":"sec-edgar","filing":"0001437749-16-042120","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/820081/000143774916042120/rdgdoc.xml","form_type":"4"}},{"id":4573296,"issuer":{"id":153359,"kind":"organization","name":"CAMBREX CORP","symbol":"CBM"},"owners":[{"id":37639,"kind":"person","name":"SARGEN GREGORY","position":1,"cik":"0001227835","reported_name":"SARGEN GREGORY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Stock Option (right to buy)","published_at":"2016-10-28T16:08:21.000Z","date":"2016-10-26","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, representing a right to purchase a total of 30,000 shares, becomes exercisable in four equal installments beginning on October 26, 2017, which is the first anniversary of the date on which the option was granted."}],"balance_after":30000,"derivative":{"exercise_price":40.65,"expiration_date":"2023-10-26","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000820081-16-000062","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/820081/000082008116000062/edgar.xml","form_type":"4"}}]}